This narrative review examines the factors associated with bronchopulmonary dysplasia in premature infants. It focuses on high-risk factors for developing this lung condition and major nursing interventions used to care for these vulnerable babies. The authors gathered information from existing reports to understand the current landscape of care and risk. No specific study size or follow-up period was reported in this review. Safety concerns were not detailed because the review did not analyze specific adverse events or discontinuations from a single trial. Because this is a narrative review rather than a new experiment, it summarizes what is already known rather than testing a new treatment. Readers should understand that this type of article provides a broad overview of the topic. It helps clinicians and families see the big picture of nursing care and risk factors. However, because it is not a new study, it does not prove that one specific action causes a specific result. The information is useful for general understanding but should be combined with other evidence when making care decisions.
Narrative review examines high-risk factors and major nursing interventions for bronchopulmonary dysplasia in premature infantsNursing care and risk factors for lung disease in premature babies
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review focuses on high-risk factors for the development of bronchopulmonary dysplasia and major nursing interventions within the population of premature infants. The scope of the article encompasses these specific areas of care but does not include a randomized controlled trial or a systematic review of primary data. Consequently, no pooled effect sizes or specific numerical results are presented in the text.
Key limitations acknowledged by the authors include the absence of reported sample sizes, study settings, and follow-up durations. Additionally, data regarding primary outcomes, secondary outcomes, and adverse events were not reported in the source material. The review does not provide specific tolerability data or discontinuation rates for any interventions discussed.
Because the source is a narrative review rather than a primary trial, causal language is avoided, and practice relevance is described as not reported. Clinicians should interpret these qualitative findings with caution, recognizing that the lack of quantitative data prevents precise risk stratification or efficacy estimation for nursing interventions in this population.